0      0

T22 - What's New in Lipid Injectable Emulsion Safety (T22)

‐ Mar 23, 2021 11:00am

Overview of the ASPEN Lipid Injectable Emulsion Survey Recommendations: Adult and Pediatric Populations

Jay Mirtallo, MS, RPh, BCNSP, FASHP, FASPEN, Clinical Practice Specialist, ASPEN; Professor Emeritius, College of Pharmacy, The Ohio State University, Columbus, OH

Lipid Injectable Emulsions: Safety Considerations in the Adult Population
Phil Ayers, PharmD, BCNSP, FMSHP, FASHP, Chief, Clinical Pharmacy Services, Mississippi Baptist Medical Center; Clinical Associate Professor, University of Mississippi School of Pharmacy, Jackson, MS

Pediatrics and Safe Use of Injectable Lipid Emulsions
Mary Petrea Cober, PharmD, BCNSP, BCPPS, FASPEN, Clinical Pharmacy Coordinator, Neonatal Intensive Care Unit; PGY1 Pharmacy Residency Director, Akron Children's Hospital; Associate Professor - Pharmacy Practice, Northeast Ohio Medical University, Akron, OH

Phil Ayers, PharmD, BCNSP, FMSHP, FASHP

Presented by the ASPEN Pharmacy Practice Section

Bear Pediatric IconThis session contains pediatric content

Live video feed supported by: Fresenius Kabi

custom image

Learning Objectives:

  • Provide an overview of the adult and pediatric versions of the ASPEN Lipid Injectable Emulsion Safety Recommendations
  • Discuss safety considerations for lipid injectable emulsions for use in the adult population
  • Describe important safety consideration when using lipid injectable emulsions in the pediatric population